<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3725164/" ref="ordinalpos=2937&amp;ncbi_uid=5131873&amp;link_uid=PMC3725164" image-link="/pmc/articles/PMC3725164/figure/F1/" class="imagepopup">Figure 1.  From: The timing of TGF-? inhibition affects the generation of antigen-specific CD8+ T Cells. </a></div><br /><div class="p4l_captionBody"><b>TGF-β signaling pathway.</b> Panel <b>A</b>: unimpeded TGF-β signaling pathway: 1. Ligand binding induces TGF-β receptor type II (TGF-βRII) dimerization. 2. TGF-β type I (TGF-βRI) receptor recruitment. 3. TGF-βRI phosphorylation and activation. 4. SMAD phosphorylation by TGF-βRI. 5. Co-SMAD4 binding. 7. Translocation to the nucleus to activate or repress target genes. Panel <b>B</b>: sTGF-βR-mediated inhibition of TGF-β signaling. 1. Ligand does not bind TGF-βRII. 2. TGF-βRI is not recruited, phosphorylated, and activated. 3. Downstream effect is inhibition of TGF-βRII mediated phosphorylation of SMAD proteins.</div></div>